老虎证券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Lpath
2.94
-0.0701
-2.33%
成交量：
1.47万
成交额：
4.31万
市值：
- -
市盈率：
- -
高：
3.02
开：
3.02
低：
2.93
收：
3.01
52周最高：
5.88
52周最低：
1.68
股本：
- -
流通股本：
- -
量比：
- -
换手率：
- -
股息：
- -
股息率：
- -
净资产收益率：
--
总资产收益率：
--
市净率：
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字：
Lpath
交易所：
NASDAQ
成立时间：
- -
员工人数：
- -
公司地址：
- -
官网：
http://www.lpath.com
邮编：
- -
电话：
- -
传真：
- -
简介：
Lpath, Inc.是一家生物科技公司，专注于脂类基础治疗性抗体的开发与研究，这是一个医疗科学的新兴领域，针对带有生物活性的信号脂质来治疗一系列人类疾病。公司目前有两个候选产品位于临床开发阶段，一个产品位于临床前评估阶段。 Lpath, Inc是发现和开发中和生物活性脂质的单克隆抗体的行业领跑者。脂质研究（称作lipidomics）是一个新兴研究领域，目前已经发现的具有生物活性会促成疾病的有几十个，如果在该领域的资金继续投入的话，还将有数百个相关发现。一旦引起疾病的脂质确定下来接下来的挑战就是生产一种能中和相关生物活性脂质的复合物。通过其免疫Y2平台技术和强大的专利财产，Lpath处在唯一能够面对这些挑战，利用机遇的地位。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LPTN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LPTN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LPTN\",,,,,undefined,":{"symbol":"LPTN","market":"US","secType":"STK","nameCN":"Lpath","latestPrice":2.94,"timestamp":1483045200000,"preClose":3.0101,"halted":0,"volume":14706,"delay":0,"changeRate":-0.02328826284841037,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-0.0701,"latestTime":"03-24 14:34:32 EDT","open":3.02,"high":3.02,"low":2.93,"amount":43088.58,"amplitude":0.029899,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.0101,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LPTN\",,,,,undefined,":{"symbol":"LPTN","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":3.02,"amplitude":0.029899,"preClose":3.0101,"low":2.93,"week52Low":1.68,"pbRate":"--","week52High":5.88,"institutionHeld":0,"latestPrice":2.94,"eps":0,"divideRate":0,"volume":14706,"delay":0,"open":3.02,"prevYearClose":16.115},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LPTN\",params:#limit:5,,,undefined,":[{"date":"2016-12-30","symbol":"LPTN","reason":"合并为APEN","type":"delisting","dateTimestamp":1483074000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LPTN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LPTN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.lpath.com","stockEarnings":[{"period":"1week","weight":-0.8176},{"period":"1month","weight":-0.8176},{"period":"3month","weight":-0.8176},{"period":"6month","weight":-0.8176},{"period":"1year","weight":-0.8176},{"period":"ytd","weight":-0.8176}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lpath, Inc.是一家生物科技公司，专注于脂类基础治疗性抗体的开发与研究，这是一个医疗科学的新兴领域，针对带有生物活性的信号脂质来治疗一系列人类疾病。公司目前有两个候选产品位于临床开发阶段，一个产品位于临床前评估阶段。 Lpath, Inc是发现和开发中和生物活性脂质的单克隆抗体的行业领跑者。脂质研究（称作lipidomics）是一个新兴研究领域，目前已经发现的具有生物活性会促成疾病的有几十个，如果在该领域的资金继续投入的话，还将有数百个相关发现。一旦引起疾病的脂质确定下来接下来的挑战就是生产一种能中和相关生物活性脂质的复合物。通过其免疫Y2平台技术和强大的专利财产，Lpath处在唯一能够面对这些挑战，利用机遇的地位。","exchange":"NASDAQ","name":"Lpath","nameEN":"Lpath"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LPTN\",market:\"US\",,,undefined,":null}}